S&P 500 Consumer Staples Sector SEC Filings — April 15, 2026

15-04-2026

Basin Electric Power Cooperative filed an S-4 registration statement on April 15, 2026, for an exchange offer to exchange up to $700,000,000 aggregate principal amount of its outstanding 5.850% First Mortgage Obligations, 2025 Series A Bonds due 2055 (Original Bonds, CUSIP Nos. 070101 AJ9 and U06865 AB2) for a like principal amount of registered Exchange Bonds (CUSIP No. 070101 AK6). The Exchange Bonds have substantially identical terms to the Original Bonds except for the removal of transfer restrictions, registration rights, and additional interest provisions. The offer expires at 5:00 p.m., New York City time, on a date in 2026 (to be specified), unless extended, and will not increase the company's outstanding indebtedness as exchanged Original Bonds will be retired.

• ·Exchange Bonds secured equally and ratably under Amended and Restated Indenture dated May 5, 2015, by mortgage lien on substantially all owned tangible and certain intangible properties.
• ·No public market currently exists for Original Bonds; no plans to list Exchange Bonds.
• ·Broker-dealers receiving Exchange Bonds must deliver prospectus for resales for up to 180 days post-expiration.

15-04-2026

Total revenue increased approximately 5% YoY to $41,441,030 in 2025 from $39,492,012, primarily driven by 5.6% growth in healthcare revenue to $41,375,235, though rental revenue fell to zero following the sale of Goodwill Hunting LLC. Operating expenses rose 1.9% to $43,005,701, but the net loss attributable to common stockholders improved significantly to $1,053,252 ($0.34 per share) from $2,446,461 ($0.80 per share), aided by lower interest expense and income from employee retention credits. However, the company still reported an operating loss of $1,564,671 and faces ongoing risks from occupancy declines, tenant insolvency, increased operational costs, and liquidity pressures related to the pandemic.

• ·Sale of Goodwill Hunting LLC on June 18, 2024 eliminated operating leases from balance sheet.
• ·Senior Secured Promissory Notes increased to $1,591,238 at Dec 31, 2025 from $1,025,000.
• ·Fixed-Rate Mortgage Loans: $24,258,870 at Dec 31, 2025 vs $25,152,756.
• ·Two loans refinanced in Feb 2026 totaling approx. $5.2M with maturity Feb 17, 2027; facilities sold Jan 2026 repaying $5,772,098 principal.
• ·Mortgage at Southern Hills Campus refinanced for 35 years at 2.38% maturing Oct 1, 2056.

15-04-2026

15-04-2026

Alta Equipment Group Inc. filed a DEFA14A Definitive Additional Proxy Materials on April 15, 2026, pursuant to Section 14(a) of the Securities Exchange Act of 1934. The filing was made by the registrant with no fee required. No substantive financial or operational details are provided in this procedural document.

• ·Filed by the Registrant (checked box)
• ·No fee required (checked box)

15-04-2026

Chunghwa Telecom reported total revenues of NT$236.1 billion in 2025, up 2.7% YoY from NT$230.0 billion in 2024 and 5.9% from NT$223.2 billion in 2023, driven by growth in Others (+27.7% YoY) and Enterprise Business (+2.4% YoY), while Consumer Business grew modestly (+2.4% YoY) but declined slightly as a percentage of total to 60.7%. Consolidated net income rose 5.2% YoY to NT$40.5 billion, with operating income up 3.6% to NT$48.6 billion; however, International Business revenues fell 4.0% YoY to NT$9.5 billion, net cash from operations dipped 2.1% to NT$77.5 billion, and operating margin remained relatively flat around 20.6%. Capital expenditures declined to NT$27.7 billion in 2025, with guidance for NT$31.9 billion in 2026, and dividends increased to NT$5.2000 per share (total NT$40.3 billion).

• ·Capex guidance for 2026: NT$31.9 billion total, with Mobile 24% (NT$7.7B) and Others 76% (NT$24.2B).
• ·Cash and cash equivalents at end of 2025: NT$36.9 billion.
• ·Noncontrolling interests in net income 2025: NT$1.8 billion (up from NT$1.3B in 2024).

15-04-2026

Motive Wealth Advisors filed its Form 13F-HR on April 15, 2026, disclosing 92 equity holdings as of March 31, 2026, consisting primarily of sole discretionary positions in large-cap stocks and ETFs. Notable positions include Schwab Strategic Trust Broad Market ETF (474,496 shares), Vanguard Tax-Managed Funds Van FTSE Dev Mkt (346,246 shares), and NVIDIA Corporation (26,181 shares), alongside other significant holdings in Apple Inc. (15,937 shares) and Amazon.com Inc. (10,653 shares). No market values or changes from prior periods are reported in the filing.

• ·Report period end date: March 31, 2026
• ·All positions reported as sole discretionary ownership with no options or shared voting/discretion
• ·Contact: Aryn Sands, Agent, Reno NV

15-04-2026

Strawberry Fields REIT, Inc. disclosed various risk factors in an 8-K filing, highlighting heavy concentration risks with 86.8% of annualized base rent from 15 master leases affiliated with executives Moishe Gubin and Michael Blisko, and 97.7% derived from skilled nursing facilities. The company also faces substantial indebtedness of $752.1 million as of December 31, 2025, along with vulnerabilities from related-party leases not negotiated at arm's length, potential tenant defaults, labor shortages, inflation, and dependence on key personnel. These factors could materially adversely affect operations, financial condition, and distributions to stockholders.

• ·Leases with related parties not negotiated on arm’s-length basis and subject to conflicts of interest policies requiring audit committee approval.
• ·Tenants under master leases are affiliates, increasing risk of widespread defaults from single adverse events like regulatory exclusions from Medicare/Medicaid.
• ·Portfolio lacks diversification, with tenant base limited to skilled nursing operators dependent on government reimbursements.

15-04-2026

R.H. Dinel Investment Counsel, Inc. filed its 13F-HR report disclosing $123613204 in total holdings across 40 securities as of March 31, 2026, all held on a sole discretionary basis with no shared voting authority or other managers reported. Top positions include Microsoft Corp ($16866796, 45565 shares), Starbucks Corp ($5883823, 65675 shares), and Adobe Systems Incorporated ($5032971, 20705 shares). No period-over-period changes or performance metrics are provided in the filing.

• ·All 40 holdings reported as SH SOLE with 0 SH PRN (put/call), 0 SH SVRD, and 0 OTHER.
• ·Filing effective date: April 15, 2026; date as of change: April 14, 2026.
• ·Business address: 11661 San Vicente Blvd., Suite 400, Los Angeles, CA 90049.

15-04-2026

Koesten, Hirschmann & Crabtree, INC. filed its 13F-HR report disclosing 41 equity positions with a total market value of $205247059 as of March 31, 2026. The portfolio is dominated by ETFs, including top holdings such as Schwab Strategic TR Fundamental US L (47477395), Schwab Strategic TR Intl Eqty ETF (23823595), Vanguard Index Fds Large Cap ETF (36308306), and Schwab Strategic TR US Lrg Cap ETF (20658353), alongside smaller positions in individual stocks like Apple Inc (2216253) and Microsoft Corp (388947). No changes, options, or other voting powers beyond sole discretionary are reported.

• ·Report filed April 15, 2026; period end March 31, 2026
• ·All 41 positions held with sole voting and sole discretionary power (SH SOLE)
• ·No put/call options or other managers reported for any position

15-04-2026

Brookfield Asset Management Ltd. (BAM) announced on April 14, 2026, an offering of US$550 million principal amount of 4.832% senior notes due 2031 and US$450 million re-opening of its existing 5.298% senior notes due 2036. The re-opening will increase the aggregate principal amount of the 2036 notes series from the previously issued US$400 million (on November 18, 2025) to US$850 million. Preliminary and final Canadian term sheets for the notes are filed as Exhibits 99.1 and 99.2.

• ·Filing submitted on April 15, 2026, pursuant to Items 8.01 and 9.01 of Form 8-K.
• ·Notes offerings incorporate term sheets into BAM’s Registration Statement on Form F-10 (File No. 333-293350).

15-04-2026

Regis Corporation (Nasdaq: RGS) announced the appointment of William 'Bill' Charters as an independent director, effective April 24, 2026, adding expertise in capital markets, restructurings, and franchise models from one of its largest individual shareholders. Susan Lintonsmith, President and CEO, highlighted his value in executing the transformation strategy and enhancing shareholder value. The Board now consists of seven directors, six independent.

• ·Mr. Charters is a CFA charterholder with experience at Botti Brown Asset Management (multi-billion-dollar hedge fund).
• ·Investor contacts: James Carbonara (646-755-7412) and Brett Maas (646-536-7331) at Hayden IR.

15-04-2026

Mount Logan Capital Inc. appointed Jordan Mangum, age 33, as Executive Vice President and Chief Operating Officer effective April 13, 2026, following a board decision on April 9, 2026. Mr. Mangum will continue his role as a Director on the credit team at BC Partners Advisors L.P. (BCPA), with services provided under the Staffing and Resource Agreement (dated November 18, 2025) and Servicing Agreement (dated March 17, 2023). Potential conflicts of interest exist due to the Company's reliance on BCPA for asset management and BCPA's minority equity interest via an affiliate.

• ·Mr. Mangum joined BCPA in March 2022, worked at Onex Private Credit division from March 2020 to March 2022, and held roles at Bank of America Merrill Lynch Global Corporate and Investment Banking from February 2015 to March 2020.
• ·Mr. Mangum holds a B.S. in Finance and a B.S. in Accounting from the Pamplin College of Business at Virginia Tech.
• ·No family relationships with current directors or officers; no new compensatory arrangements with the Company.

15-04-2026

Prelude Therapeutics Incorporated (Nasdaq: PRLD) announced the appointment of Dr. Charles Morris, M.D. as Chief Medical Officer effective April 20, 2026, to lead the advancement of its two lead programs targeting myeloproliferative neoplasms and ER+ breast cancer into clinical development in 2026. Dr. Morris brings over 30 years of oncology drug development experience, including prior CMO roles at Lava Therapeutics, Celyad Oncology, Radius Health, ImmunoGen, and Allos Therapeutics, and contributions to approvals of ONSERDU, ELAHERE, and Faslodex. CEO Kris Vaddi highlighted Dr. Morris's expertise as instrumental for executing these programs with rigor.

• ·Dr. Morris holds a medical degree and Bachelor of Medical Science in Clinical Pharmacology and Therapeutics from Sheffield University Medical School and is a Member of the Royal College of Physicians of London.
• ·Investor contact: Robert A. Doody, Jr. at 484.639.7235 or rdoody@preludetx.com

15-04-2026

Wealth Intelligence, LLC disclosed total equity holdings of $207,953,897 across 58 positions in its 13F-HR filing as of March 31, 2026. The portfolio is concentrated with Lowe's Companies Inc. as the largest holding at $71,280,699 (301,679 shares), followed by First Trust Exchange-Traded FD Core Investment at $19,748,093 (942,180 shares) and Apple Inc. at $6,697,645 (26,390 shares). All positions are held solely on a discretionary basis with no other voting authority or shared discretion reported.

• ·Filing submitted on April 15, 2026, for period ending March 31, 2026
• ·Headquartered at 2900 Warm Springs Rd, Columbus, GA 31904
• ·58 holdings all reported as SH SOLE (sole discretionary voting authority)

15-04-2026

Register Financial Advisors LLC disclosed $270,530,847 in total equity holdings across 387 positions in its 13F-HR filing as of March 31, 2026, all held on a sole discretionary basis. Top holdings by value include Apple Inc ($9,930,750 for 39,130 shares), JPMorgan Chase & Co ($5,059,943 for 17,201 shares), Kratos Defense & Security Solutions ($4,791,437 for 67,954 shares), ATI Inc ($4,342,418 for 29,853 shares), and Honeywell Intl Inc ($3,976,763 for 17,594 shares). No prior period data is provided in the filing for comparison.

• ·Filing date: April 15, 2026
• ·Report period end: March 31, 2026
• ·All reported holdings are SH SOLE (sole discretionary voting authority)
• ·One put/call position noted: Enovix Corporation 20,000 SH Call ($103,600 value)

15-04-2026

Pinnacle West Capital Corporation and Arizona Public Service Company filed a Form 8-K on April 15, 2026, under Items 7.01 (Regulation FD Disclosure) and 9.01, announcing participation in meetings with securities analysts and investors during April 2026. Handouts for these meetings are attached as Exhibit 99.1. No financial results or performance metrics were disclosed in the filing.

15-04-2026

Lakeland Financial Corp (LKFN) held its annual shareholder meeting on April 14, 2026, electing 13 directors including A. Faraz Abbasi, Blake W. Augsburger, and others with terms expiring in 2027; most received strong support with over 19M 'For' votes, though Abbasi and Bradley J. Toothaker saw higher 'Withhold' votes of 4,267,983 and 4,152,574 shares, respectively. Shareholders approved the advisory vote on executive compensation with 14,741,820 'For' versus 4,859,374 'Against', and ratified Crowe LLP as independent auditor for the year ended December 31, 2026, with overwhelming support of 22,283,808 'For' votes.

• ·All director elections had consistent broker non-votes of 2,872,162 shares.
• ·Auditor ratification had no broker non-votes, with only 3,031 abstain/withhold votes.
• ·Executive compensation advisory vote had 111,686 abstain/withhold votes.

15-04-2026

Mountain Lake Acquisition Corp., a SPAC, filed Form 425 disclosing social media communications by Laine Litman and Pubco regarding the Business Combination Agreement dated October 1, 2025, with Avalanche Treasury Corporation (Pubco), Avalanche Treasury Company LLC (Newco), and other entities including a concurrent private placement. The filing provides standard forward-looking statement disclaimers, highlights risks such as transaction failure, high redemptions, and AVAX price volatility, and urges investors to review the upcoming Registration Statement on Form S-4 and Proxy Statement/Prospectus. No financial metrics or performance data are disclosed.

• ·Business Combination Agreement dated October 1, 2025
• ·Social media communications dated April 14, 2026 (Laine Litman LinkedIn), April 11, 2026 (Laine Litman X), and April 9, 2026 (Pubco X and LinkedIn)
• ·Mountain Lake contact: 930 Tahoe Blvd STE 802 PMB 45, Incline Village, NV 89451; (775) 204-1489
• ·Registration Statement on Form S-4 filed by Pubco and Newco

15-04-2026

Ford Motor Co (CIK: 0000037996) filed an 8-K on April 15, 2026, under Items 5.02 (Director/Officer Departure/Election), 7.01 (Regulation FD Disclosure), and 9.01 (Financial Statements and Exhibits), indicating potential changes in directors or officers alongside other disclosures. The filing size is 2 MB, part of ongoing regulatory updates. No specific financial metrics, performance changes, or detailed personnel details are available in the provided filing index.

• ·Filing accession number: 0000037996-26-000081
• ·Subcategory: Director/Officer Departure/Election
• ·Mailing/Business Address: One American Rd, Dearborn, MI 48126
• ·Phone: 3133223000
• ·SIC: 3711 (Motor Vehicles & Passenger Car Bodies)
• ·Fiscal Year End: December 31

15-04-2026

Costco Wholesale Corporation's Board of Directors declared a quarterly cash dividend increase from $1.30 to $1.47 per share, equating to $5.88 on an annualized basis. The dividend is payable on May 15, 2026, to shareholders of record at the close of business on May 1, 2026. This represents a positive signal of financial confidence with no reported declines or flat metrics.

• ·Filing includes Exhibit 99.1: Press release dated April 15, 2026.

15-04-2026

Exelixis, Inc. filed its DEF 14A Proxy Statement for the virtual 2026 Annual Meeting of Stockholders on May 26, 2026, at 9:00 a.m. PT, soliciting votes on electing eleven director nominees, ratifying Ernst & Young LLP as independent auditors for the fiscal year ending January 1, 2027, approving an amendment to the 2017 Equity Incentive Plan increasing authorized shares by 2,000,000, and an advisory vote on Named Executive Officer compensation. The record date is March 31, 2026, with 254,008,174 shares of common stock outstanding entitled to vote. No financial performance metrics or period-over-period comparisons are detailed in the provided filing content.

• ·Annual Meeting held virtually at www.virtualshareholdermeeting.com/EXEL2026; requires 16-digit control number to attend and vote.
• ·Proxy voting deadline: 11:59 p.m. ET on May 25, 2026, via internet or phone.
• ·Fiscal year ended January 2, 2026; Annual Report on Form 10-K filed February 10, 2026.
• ·Stockholder list available 10 days prior to meeting at principal offices (1851 Harbor Bay Parkway, Alameda, CA 94502) or via virtual meeting site.

15-04-2026

QuidelOrtho announced preliminary unaudited Q1 2026 revenue of $615-620 million, lower than expected due to a weaker respiratory season with U.S. Influenza-like Illness visits down approximately 30% YoY, slower China distributor sales from proposed NHSA reimbursement reductions, and delayed EMEA orders from the Middle East conflict. The core business, representing more than 70% of total revenue, remains strong, though Q1 free cash flow is projected at $(65)-(70) million as anticipated. The company states the low end of its full-year 2026 guidance, issued February 11, 2026, remains achievable.

• ·Q1 2026 ended March 29, 2026; full results and conference call scheduled for May 5, 2026 at 2:00 p.m. PT / 5:00 p.m. ET.
• ·Full-year 2026 free cash flow expected positive; H1 2026 free cash flow expected negative as previously guided.

15-04-2026

nVent Electric plc reported strong 2025 continuing operations results with sales of $3.9 billion, up 30% overall and 13% organically, driven by acquisitions adding 16 points, data center sales growing over 50% to ~$1 billion, and backlog of $2.3 billion. The company achieved adjusted EPS of $3.35 (up 35%), free cash flow of $561 million (up 31%), and 51% annualized total shareholder return outperforming peers. Shareholder engagement reached holders of 12% of shares, highlighting governance practices, board nominees with diverse skills, sustainability progress, and pay-for-performance alignment with MIP payouts at 185% and PSUs at 200%.

• ·Organic sales growth led by Infrastructure segment, now 45% of total sales
• ·Launched 100% of new products without single-use plastic packaging
• ·Shareholder engagement included Director participation on 100% of calls
• ·2023-2025 MIP payouts: 139%, 98%, 185%; PSU payouts all at 200%

15-04-2026

Constellation Acquisition Corp I reported a widened net loss of $3,239,103 for the year ended December 31, 2025, compared to $248,243 in 2024, driven by a $2,275,191 negative change in warrant liabilities and reduced interest income, though general and administrative costs decreased 32% to $1,068,743. Cash in the Trust Account plummeted 97% to $859,443 from $28,123,011 due to heavy redemptions of 2,303,382 Class A ordinary shares, increasing total liabilities to $23,303,004 and deepening shareholders' deficit to $(23,261,238). While cash used in operating activities improved slightly to $(470,238), related party debt rose with promissory notes at $2,122,109.

• ·Warrant liabilities increased to $2,527,991 from $252,800.
• ·Accounts payable and accrued expenses rose to $4,261,904 from $3,802,862.
• ·Cash withdrawn from Trust Account in connection with redemptions: $27,428,399 in 2025 vs. $23,671,533 in 2024.
• ·Proceeds from promissory notes to related party: $529,901 in 2025.

15-04-2026

KRS Capital Management, LLC filed its 13F-HR on April 15, 2026, reporting total holdings of $163,113,338 across 115 positions as of March 31, 2026. Top holdings include NVIDIA Corporation ($40,889,082, 234,455 shares), Apple Inc ($16,862,377, 66,442 shares), and Broadcom Inc ($5,021,592, 16,224 shares), with a heavy concentration in technology and semiconductor stocks. All positions are held with sole voting and investment discretion.

• ·Report period end date: March 31, 2026
• ·Filing date: April 15, 2026
• ·All holdings reported as SH SOLE with no other managers or options

15-04-2026

Luke Kissam resigned from the Board of Directors of DuPont de Nemours, Inc. effective April 14, 2026, to assume the role of Chief Executive Officer at Corteva, Inc. The departure was not due to any disagreement with the Company's operations, policies, or practices. In response, the Board approved a reduction in its size from 11 to 10 members.

• ·Resignation tendered on April 13, 2026
• ·Date of Report (earliest event): April 13, 2026
• ·Filing date: April 15, 2026

15-04-2026

Sotherly Hotels LP reported total revenue of $176,387,228 for the year ended December 31, 2025, down 3.0% YoY from $181,894,287, with rooms revenue declining to $114,400,434 from $119,079,903 while food and beverage remained relatively flat at $36,458,606. Net operating income fell sharply 38.5% YoY to $12,696,273 from $20,647,862, driven by higher interest expense of $24,799,871 (up 18.8%), resulting in a net loss of $7,779,133 versus net income of $1,179,854 in 2024; Adjusted FFO decreased to $4,873,022 from $14,290,221. Total assets declined to $407,913,819 from $414,375,920, with equity dropping to $28,260,815 from $41,598,766 amid ongoing preferred distributions.

• ·Mortgage loans, net decreased slightly to $315,199,862 from $316,516,148.
• ·Cash flows from operating activities $10,315,065 in 2025, down from $25,889,146 in 2024.
• ·Impairment of investment in hotel properties held for sale: $1,310,308 in 2025.
• ·Preferred stock liquidation preferences increased: Series B to $45,387,100, Series C to $41,603,220, Series D to $36,274,181 as of Dec 31, 2025.

15-04-2026

Intelligent Protection Management Corp. (IPM) has filed a DEF 14A proxy statement for its 2026 Annual Meeting on May 7, 2026, at 9:00 a.m. ET (virtual webcast), seeking to elect seven directors and ratify Grassi & Co., CPAs, P.C. as independent auditors for the year ending December 31, 2026. In fiscal 2025, IPM completed its first full year post-acquisition of Newtek Technology Solutions, Inc., achieving managed recurring revenue growth, expense optimization, risk management improvements, retention of all major clients with near-zero churn, and expansion into new markets. The Board recommends voting FOR both proposals, with a record date of March 27, 2026.

• ·Record date: March 27, 2026, 5:00 p.m. ET.
• ·Annual Meeting access: https://edge.media-server.com/mmc/p/tid8riw2.
• ·Proxy materials and 2025 Annual Report available at: http://www.astproxyportal.com/ast/24835.
• ·Fiscal year end: December 31.
• ·Company address: 30 Jericho Executive Plaza, Suite 400E, Jericho, NY 11753.
• ·Investor Relations contact: IR@ipm.com or (212) 967-5120.

15-04-2026

PPG reported preliminary Q1 2026 EPS of $1.70 (reported) and $1.83 (adjusted), a 6% increase from Q1 2025 adjusted EPS of $1.72, marking the fifth consecutive quarter of organic sales growth driven by positive selling prices but flat sales volumes. Strong performance in architectural coatings Latin America and aerospace businesses resulted in segment EBITDA margins exceeding original expectations. However, Q2 2026 guidance calls for organic sales and adjusted EPS to range from flat to low single-digit growth versus the prior year period.

• ·Acquisition-related amortization expense: $0.09 per share in Q1 2026 vs $0.10 in Q1 2025.
• ·Business restructuring-related costs, net: $0.02 per share in Q1 2026 vs $0.03 in Q1 2025.
• ·Insurance recovery: $0.02 per share benefit in Q1 2025.
• ·Detailed Q1 2026 financial results to be announced April 28, 2026 after U.S. markets close.
• ·Earnings teleconference scheduled for April 29, 2026 at 8 a.m. ET.

15-04-2026

Eline Entertainment Group, Inc. (EEGI) reported zero revenues for both years ended December 31, 2025 and 2024, with net losses widening to $44,992 in 2025 from $32,877 in 2024 (37% YoY increase in loss magnitude). Operating expenses rose 26% YoY to $44,992, driven by a 768% surge in other G&A expenses to $12,492 despite a slight 4% decline in professional fees to $32,500; total liabilities grew 50% to $134,301, primarily due to increased related party payables. Cash remained at zero, with operating cash burn increasing 32% to $49,191, fully funded by related party advances.

• ·Total assets and cash balances remained at $0 as of Dec 31, 2025 and 2024.
• ·Stockholders’ deficit increased to $(134,301) as of Dec 31, 2025 from $(89,309) as of Dec 31, 2024.
• ·No depreciation/amortization, investing activities, income taxes paid, or interest paid in either year.
• ·Audited by Beckles & Co. Inc. (PCAOB ID: 7116).

15-04-2026

Limoneira Company announced the completion of definitive agreements for a 50%/50% joint venture with Agromin to develop a 70-acre commercial composting center on its Santa Paula property, expanding from an existing 15-acre operation to process approximately 295,000 tons of organic waste annually, with operations expected in the second half of fiscal year 2027. The facility will generate revenue from gate fees and compost sales, sharing significant EBITDA equally between partners, while Limoneira will lease the site for approximately $560,000 annually including 89-acre feet of water. This initiative supports California's Senate Bill 1383 organic waste diversion mandates, positioning the center as the only permitted commercial composting facility in Ventura County, expected to divert 75% of the county's landfilled organic waste.

• ·Joint venture follows letter of intent announced in April 2025.
• ·15 years of planning and permitting required for food waste processing.
• ·Limoneira headquartered in Santa Paula, California, with operations in California, Arizona, and Argentina.
• ·Agromin headquartered in Oxnard, California, and is a U.S. Composting Council Composter of the Year recipient.

15-04-2026

Invesco Mortgage Capital Inc. issued a press release on April 15, 2026, announcing its monthly common stock dividend and providing preliminary financial data as of March 31, 2026, including updates on book value, investment portfolio, liquidity, repurchase agreements, and leverage. As of April 10, 2026, book value per common share is estimated in the range of $8.21 to $8.55 (adjusted to exclude a pro rata portion of the declared dividend), calculated as total stockholders' equity less $169.4 million Series C Preferred Stock liquidation preference, divided by 89.0 million common shares outstanding.

15-04-2026

Marvell Technology, Inc. completed a public offering of $1,000,000,000 aggregate principal amount of its 5.300% Senior Notes due 2036 on April 15, 2026, governed by the Fifth Supplemental Indenture with U.S. Bank Trust Company, National Association. Net proceeds of approximately $993.5 million, after underwriters' discount but before other expenses, will be used for repayment of debt including the Company's 1.650% senior notes due 2026, and general corporate purposes such as working capital, dividends, capital expenditures, stock repurchases, and acquisitions. The notes accrue interest at 5.300% per year, payable semi-annually starting October 15, 2026, and mature on April 15, 2036.

• ·Underwriting Agreement dated April 6, 2026, among the Company and representatives Wells Fargo Securities, LLC, BofA Securities, Inc., J.P. Morgan Securities LLC and Mizuho Securities USA LLC.
• ·Prior to par call date of January 15, 2036, Notes redeemable at greater of discounted value using Treasury Rate plus 15 basis points or 100% principal.
• ·Offered pursuant to shelf registration statement on Form S-3 (No. 333-285742) filed March 12, 2025.

15-04-2026

ADMA Biologics, Inc. filed Definitive Additional Proxy Materials (DEFA14A) on April 15, 2026, pursuant to Section 14(a) of the Securities Exchange Act of 1934. The filing is made by the registrant with no fee required. No specific shareholder proposals, financial data, or voting details are included in the provided filing header.

15-04-2026

Cosmos Health Inc. reported growth in select areas, including a 15% YoY increase in wholesale revenues at Cosmofarm S.A., pharmaceutical manufacturing revenues at CANA S.A. nearly doubling from $865,000 to $1.7 million, and UK subsidiary Decahedron Ltd. revenues rising from $815,000 to $2.6 million in 2025. However, the company posted a wider net loss of $19,144,998 compared to $16,183,018 in 2024, driven by high provisions for doubtful accounts of $5,882,393, increased G&A expenses like $2.0 million in management bonuses and $2,312,241 in stock-based compensation, and impairments of $162,785. Total inventory stood at $5,778,142 as of December 31, 2025, with pharmaceuticals comprising 74.73%.

• ·Provisions include $1,400,020 against Montreal land/building advances and $533,288 on other receivables.
• ·Impairments: $90,450 on Cosmofarm e-commerce platform and $72,335 on pharmaceutical licenses.
• ·ATW facility allows up to $300 million, with $292 million available post-initial $8 million draw.
• ·New S-3 registers up to $200,000,000 of securities.
• ·Accounts receivable increase caused $4,939,952 cash outflow.

15-04-2026

Oncotelic Therapeutics reported a dramatic turnaround with net income attributable to the company of $249,279,832 in 2025 versus a $4,523,932 loss in 2024, driven by a $365,346,775 positive change in fair value of its investment in GMP Bio, which surged to $388,000,000 from $22,653,225, boosting total assets to $393,088,242 from $26,677,426. However, the company continued to post an operating loss of $3,186,599 (improved from $3,576,013), with general and administrative expenses rising sharply to $3,182,242 from $376,013, cash remaining low at $88,857, and working capital negative at ($16,945,000). Stockholders' equity expanded to $261,731,559 from $7,477,512 amid low liquidity and net cash used in operations of $1,383,000.

• ·Net cash used in operating activities increased to $1,383,000 in 2025 from $740,000 in 2024.
• ·Net cash provided by financing activities was $1,386,000 in 2025 versus $656,000 in 2024.
• ·Basic and diluted EPS improved to $0.59 in 2025 from ($0.01) in 2024.
• ·Deferred income tax provision of $111,550,000 in 2025.

15-04-2026

BlackRock, Inc. filed Definitive Additional Proxy Materials (DEFA14A) on April 15, 2026, consisting of an email from Caroline Rodda, Head of Investor Relations, notifying institutional investors of the 2026 Proxy Statement filed on April 10, 2026. The communication emphasizes shareholder engagement, noting that feedback from the past year informed enhancements to the disclosure. It invites questions and continued dialogue ahead of the 2026 Annual Meeting of Shareholders.

• ·Proxy materials accessible via provided link
• ·Email sent to certain institutional investors

15-04-2026

This Form 8-K/A, filed April 15, 2026, amends the original 8-K dated February 25, 2026 (further amended March 16, 2026) for Benchmark 2026-B42 Mortgage Trust by making clerical revisions to Exhibit 4.1, the Pooling and Servicing Agreement dated March 1, 2026. No other changes were made to the Form 8-K. The agreement is between Deutsche Mortgage & Asset Receiving Corporation as depositor and various master servicers, special servicers, trustee, and other parties.

• ·Date of earliest event reported: February 23, 2026
• ·Registrant’s principal executive offices: 1 Columbus Circle, New York, New York 10019
• ·Registrant’s telephone number: (212) 250-2500

15-04-2026

Valmont Industries Inc disclosed the compensation package for John Schwietz via Exhibit 99.1 in its 8-K filing. Key elements include a base salary of $525,000 per year, participation in the 2026 Annual Incentive Plan (AIP) with a target of 80% of base salary (prorated for 2026 and capped at 2x target), and Long Term Performance Share (LTIP) plans for 2025-2027 and 2026-2028 with a target of 80% of base salary (prorated from promotion date and capped at 2x target). Additional components are eligibility for a December 2026 stock grant with a target value of 160% of base salary and a stock ownership guideline of 2.5x base salary.

• ·AIP and LTIP prorated from promotion date
• ·Stock grant eligibility in December 2026

15-04-2026

Vivakor, Inc.'s 10-K for the year ended December 31, 2025, shows sharply mixed segment performance: one segment's total revenues plummeted 83.50% YoY to $11,719,760 from $71,028,495, with related party revenues down 73.30%, while another segment's total revenues surged 86.95% to $35,113,592 and a third generated new $57,585,457 in revenues (100% growth from zero). Gross profits improved significantly across segments, rising 44.21% to $7,557,424 in the first, 481.31% to $28,941,924 in the second, and emerging at $45,388 in the third; however, operating cash flow deteriorated to a $15,780,294 use from a $1,810,827 provision in 2024. Long-term contracts, including a 10-year terminal agreement in Colorado City, Texas, and an offtake with Denbury Onshore, LLC (ExxonMobil subsidiary), support recurring revenue visibility.

• ·CEO Mr. Ballengee's $1,000,000 salary paid in common stock shares: 8,286 shares for Oct 2023-Oct 2024 (VWAP $0.6034946), 3,445 shares for Oct 2024-Oct 2025 (VWAP $1.4516084), accruing 3,624 shares for Oct-Dec 2025 (VWAP $0.23), post 1-for-200 reverse stock split.
• ·Related party transactions exceed $120,000 or 1% of average total assets at year-end for last two fiscal years, involving directors, executive officers, or >5% shareholders.
• ·Multiple executive changes in 2025: Ms. Hawley appointed CFO July 24; Mr. Patterson appointed COO August 12; Mr. Nelson resigned CFO July 19; Mr. Shelton resigned COO August 3; Mr. Knapp resigned November 10.

15-04-2026

Molson Coors Beverage Company filed a DEFA14A supplement on April 15, 2026, to its proxy statement dated March 25, 2026, for the 2026 Annual Meeting on May 6, 2026. The supplement clarifies that director Jill Timm attended at least 75% of the aggregate Board and committee meetings on which she served during 2025, amending page 37 to remove her from the list of directors (now only Mr. Cocks and Mr. Hattersley) who did not meet this threshold. No other changes to the proxy statement are made.

• ·Original proxy statement filed with SEC on March 25, 2026.
• ·Supplement first made available to stockholders on April 15, 2026.

15-04-2026

Allegiant Travel Company announced on April 15, 2026, that the U.S. Department of Transportation (DOT) granted the interim exemption jointly requested with Sun Country Airlines Holdings, Inc., fulfilling a key regulatory condition for their proposed mergers outlined in the Agreement and Plan of Merger dated January 11, 2026. The mergers involve Merger Sub 1 merging with Sun Country, followed by Sun Country merging into Merger Sub 2, making Sun Country a wholly owned subsidiary of Allegiant. A joint press release detailing this progress was issued and attached as Exhibit 99.1.

• ·DOT interim exemption application previously jointly submitted by Allegiant and Sun Country.
• ·Registration Statement on Form S-4 (No. 333-294712) declared effective March 31, 2026.
• ·Definitive Joint Proxy Statement/Prospectus filed March 31, 2026.

15-04-2026

Lomond Therapeutics Holdings, Inc., an early-stage biotech with no approved products or revenue, reported a net loss of $23,531,379 for the year ended December 31, 2025, a 38% increase from $17,087,453 in 2024, driven by R&D expenses rising 41% to $20,258,461 and G&A expenses surging 116% to $4,200,525. Total operating expenses grew 50% to $24,458,986, while cash used in operating activities increased to $22,781,644 from $12,041,057, resulting in a net cash decrease of $15,214,951 despite $18,494,000 in financing inflows. Positively, interest income jumped 761% to $1,183,374, but overall cash position deteriorated from a $27,616,582 increase in 2024.

• ·No products approved for commercial sale and no revenue generated.
• ·Interest expense - related party increased 387% to $205,960 in 2025.
• ·Change in fair value of SAFE liability improved to $0 from $(833,328) (-100%).
• ·Investing activities used $10,927,307 in cash in 2025 (none in 2024).